Correction to Amgen Earnings Stories
October 27 2014 - 6:54PM
Dow Jones News
Amgen Inc. said its earnings increased in the third quarter,
driven by strong growth of key drugs such as cancer therapy
Kyprolis. "Amgen Posts Strong Results on Higher Sales--Update"
published at 5:39 p.m. and an earlier version at 4:01 p.m.
misspelled the name of drug as Krypolis in the lead of the
story.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Apr 2023 to Apr 2024